We will detail the unmet clinical need associated with the continued transmission of SARS-CoV-2, MERS-CoV and the four seasonal coronaviruses (HCoV-OC43, NL63, HKU1 and 229E) in humans and the potential for future zoonotic coronaviruses
For your convenience, Virtual Consultations are also available
Subcutaneous injections: These use shorter, thinner needles (ranging from 0.5 to 5/8 inches), as they only need to reach the fatty layer beneath the skin
They are sometimes paired in research blends because the angiogenic plus cytoskeletal pathway combination covers complementary stages of the tissue-repair process
BPC-157 (Body Protection Compound) is a stable pentadecapeptide derived from a protein found in gastric juice, studied for its broad tissue-repair activity across tendon, ligament, gut and vascular tissue
The frequency of injections can vary based on individual needs and healthcare provider recommendations, but they are often administered once or twice weekly